ATG2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.04281036531029E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.86610002397936E-09 |
Normal-vs-Stage2 |
7.16890002916415E-09 |
Normal-vs-Stage3 |
3.15303338993544E-14 |
Normal-vs-Stage4 |
1.62925228863742E-12 |
Stage1-vs-Stage2 |
1.136640E-01 |
Stage1-vs-Stage3 |
5.183300E-03 |
Stage1-vs-Stage4 |
1.049140E-04 |
Stage2-vs-Stage3 |
6.639200E-01 |
Stage2-vs-Stage4 |
1.335820E-01 |
Stage3-vs-Stage4 |
1.543410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.65278901675947E-12 |
Normal-vs-AfricanAmerican |
4.54959999673932E-08 |
Normal-vs-Asian |
9.613800E-02 |
Caucasian-vs-AfricanAmerican |
9.128200E-01 |
Caucasian-vs-Asian |
2.508200E-01 |
AfricanAmerican-vs-Asian |
3.016400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.22044604925031E-16 |
Normal-vs-Female |
7.64450003298833E-09 |
Male-vs-Female |
8.057900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.73610000054181E-07 |
Normal-vs-Age(41-60Yrs) |
8.4121998256137E-10 |
Normal-vs-Age(61-80Yrs) |
1.62614366416847E-12 |
Normal-vs-Age(81-100Yrs) |
2.08659999945127E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.639000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.658400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.267600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.293700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.352970E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.208000E-01 |
Normal-vs-Grade 2 |
5.58320000232371E-08 |
Normal-vs-Grade 3 |
1.62481139653892E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
5.987600E-02 |
Grade 1-vs-Grade 3 |
6.192700E-04 |
Grade 1-vs-Grade 4 |
4.21800000038886E-07 |
Grade 2-vs-Grade 3 |
2.365200E-04 |
Grade 2-vs-Grade 4 |
1.97359995013358E-09 |
Grade 3-vs-Grade 4 |
2.435600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.4585999996708E-07 |
Normal-vs-ccB subtype |
1.66877622831407E-12 |
ccA subtype-vs-ccB subtype |
1.115880E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.50253159808744E-12 |
Normal-vs-N1 |
4.00450006488029E-10 |
N0-vs-N1 |
4.220500E-03 |
|
|